 | • レポートコード：QYR9N7333 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、イバンドロン酸のグローバル市場について調査・分析したレポートで、種類別（経口、注入）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・イバンドロン酸の世界市場規模 ・主要企業別市場シェア ・イバンドロン酸の世界市場規模：種類別（経口、注入） ・イバンドロン酸の世界市場規模：用途別（病院、ドラッグストア） ・イバンドロン酸のアメリカ市場規模（種類別、用途別） ・イバンドロン酸のヨーロッパ市場規模（種類別、用途別） ・イバンドロン酸の中国市場規模（種類別、用途別） ・イバンドロン酸の日本市場規模（種類別、用途別） ・イバンドロン酸の東南アジア市場規模（種類別、用途別） ・イバンドロン酸のインド市場規模（種類別、用途別） ・イバンドロン酸の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・イバンドロン酸の世界市場予測（2019年-2025年） ・イバンドロン酸の地域別市場予測（2019年-2025年） ... |
Ibandronate is prescription medication used for treating osteoporosis in women after menopause. In 2018, the global Ibandronate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Ibandronate status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ibandronate development in United States, Europe and China.
The key players covered in this study
Roche
Apotex
Mylan
Sun Pharmaceutical
Dr Reddy’s Laboratories
Aurobindo Pharma
MACLEODS
…
Market segment by Type, the product can be split into
Oral
Injection
Market segment by Application, split into
Hospital
Drug store
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ibandronate status, future forecast, growth opportunity, key market and key players.
To present the Ibandronate development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ibandronate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ibandronate Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Ibandronate Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Drug store
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Ibandronate Market Size
2.2 Ibandronate Growth Trends by Regions
2.2.1 Ibandronate Market Size by Regions (2014-2025)
2.2.2 Ibandronate Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Ibandronate Market Size by Manufacturers
3.1.1 Global Ibandronate Revenue by Manufacturers (2014-2019)
3.1.2 Global Ibandronate Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Ibandronate Market Concentration Ratio (CR5 and HHI)
3.2 Ibandronate Key Players Head office and Area Served
3.3 Key Players Ibandronate Product/Solution/Service
3.4 Date of Enter into Ibandronate Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Ibandronate Market Size by Type (2014-2019)
4.2 Global Ibandronate Market Size by Application (2014-2019)
5 United States
5.1 United States Ibandronate Market Size (2014-2019)
5.2 Ibandronate Key Players in United States
5.3 United States Ibandronate Market Size by Type
5.4 United States Ibandronate Market Size by Application
6 Europe
6.1 Europe Ibandronate Market Size (2014-2019)
6.2 Ibandronate Key Players in Europe
6.3 Europe Ibandronate Market Size by Type
6.4 Europe Ibandronate Market Size by Application
7 China
7.1 China Ibandronate Market Size (2014-2019)
7.2 Ibandronate Key Players in China
7.3 China Ibandronate Market Size by Type
7.4 China Ibandronate Market Size by Application
8 Japan
8.1 Japan Ibandronate Market Size (2014-2019)
8.2 Ibandronate Key Players in Japan
8.3 Japan Ibandronate Market Size by Type
8.4 Japan Ibandronate Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Ibandronate Market Size (2014-2019)
9.2 Ibandronate Key Players in Southeast Asia
9.3 Southeast Asia Ibandronate Market Size by Type
9.4 Southeast Asia Ibandronate Market Size by Application
10 India
10.1 India Ibandronate Market Size (2014-2019)
10.2 Ibandronate Key Players in India
10.3 India Ibandronate Market Size by Type
10.4 India Ibandronate Market Size by Application
11 Central & South America
11.1 Central & South America Ibandronate Market Size (2014-2019)
11.2 Ibandronate Key Players in Central & South America
11.3 Central & South America Ibandronate Market Size by Type
11.4 Central & South America Ibandronate Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ibandronate Introduction
12.1.4 Roche Revenue in Ibandronate Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Apotex
12.2.1 Apotex Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ibandronate Introduction
12.2.4 Apotex Revenue in Ibandronate Business (2014-2019)
12.2.5 Apotex Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ibandronate Introduction
12.3.4 Mylan Revenue in Ibandronate Business (2014-2019)
12.3.5 Mylan Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ibandronate Introduction
12.4.4 Sun Pharmaceutical Revenue in Ibandronate Business (2014-2019)
12.4.5 Sun Pharmaceutical Recent Development
12.5 Dr Reddy’s Laboratories
12.5.1 Dr Reddy’s Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ibandronate Introduction
12.5.4 Dr Reddy’s Laboratories Revenue in Ibandronate Business (2014-2019)
12.5.5 Dr Reddy’s Laboratories Recent Development
12.6 Aurobindo Pharma
12.6.1 Aurobindo Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ibandronate Introduction
12.6.4 Aurobindo Pharma Revenue in Ibandronate Business (2014-2019)
12.6.5 Aurobindo Pharma Recent Development
12.7 MACLEODS
12.7.1 MACLEODS Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ibandronate Introduction
12.7.4 MACLEODS Revenue in Ibandronate Business (2014-2019)
12.7.5 MACLEODS Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Ibandronate Key Market Segments
Table Key Players Ibandronate Covered
Table Global Ibandronate Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Ibandronate Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Injection Figures
Table Key Players of Injection
Table Global Ibandronate Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Drug store Case Studies
Figure Ibandronate Report Years Considered
Table Global Ibandronate Market Size 2014-2025 (Million US$)
Figure Global Ibandronate Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Ibandronate Market Size by Regions 2014-2025 (Million US$)
Table Global Ibandronate Market Size by Regions 2014-2019 (Million US$)
Table Global Ibandronate Market Share by Regions 2014-2019
Figure Global Ibandronate Market Share by Regions 2014-2019
Figure Global Ibandronate Market Share by Regions 2019
Table Market Top Trends
Table Global Ibandronate Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Ibandronate Market Share by Manufacturers (2014-2019)
Figure Global Ibandronate Market Share by Manufacturers in 2018
Table Global Ibandronate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ibandronate Product/Solution/Service
Table Date of Enter into Ibandronate Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ibandronate Market Size by Type (2014-2019) (Million US$)
Table Global Ibandronate Market Size Share by Type (2014-2019)
Figure Global Ibandronate Market Size Market Share by Type (2014-2019)
Table Global Ibandronate Market Size by Application (2014-2019) (Million US$)
Table Global Ibandronate Market Size Share by Application (2014-2019)
Figure Global Ibandronate Market Size Market Share by Application (2014-2019)
Figure Global Ibandronate Revenue Market Share by Application in 2018
Figure United States Ibandronate Market Size 2014-2019 (Million US$)
Table United States Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table United States Key Players Ibandronate Market Share (2018-2019)
Table United States Ibandronate Market Size by Type (2014-2019) (Million US$)
Table United States Ibandronate Market Share by Type (2014-2019)
Table United States Ibandronate Market Size by Application (2014-2019) (Million US$)
Table United States Ibandronate Market Share by Application (2014-2019)
Figure Europe Ibandronate Market Size 2014-2019 (Million US$)
Table Europe Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table Europe Key Players Ibandronate Market Share (2018-2019)
Table Europe Ibandronate Market Size by Type (2014-2019) (Million US$)
Table Europe Ibandronate Market Share by Type (2014-2019)
Table Europe Ibandronate Market Size by Application (2014-2019) (Million US$)
Table Europe Ibandronate Market Share by Application (2014-2019)
Figure China Ibandronate Market Size 2014-2019 (Million US$)
Table China Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table China Key Players Ibandronate Market Share (2018-2019)
Table China Ibandronate Market Size by Type (2014-20189) (Million US$)
Table China Ibandronate Market Share by Type (2014-2019)
Table China Ibandronate Market Size by Application (2014-2019) (Million US$)
Table China Ibandronate Market Share by Application (2014-2019)
Figure Japan Ibandronate Market Size 2014-2019 (Million US$)
Table Japan Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table Japan Key Players Ibandronate Market Share (2018-2019)
Table Japan Ibandronate Market Size by Type (2014-2019) (Million US$)
Table Japan Ibandronate Market Share by Type (2014-2019)
Table Japan Ibandronate Market Size by Application (2014-2019) (Million US$)
Table Japan Ibandronate Market Share by Application (2014-2019)
Figure Southeast Asia Ibandronate Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Ibandronate Market Share (2018-2019)
Table Southeast Asia Ibandronate Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Ibandronate Market Share by Type (2014-2019)
Table Southeast Asia Ibandronate Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Ibandronate Market Share by Application (2014-2019)
Figure India Ibandronate Market Size 2014-2019 (Million US$)
Table India Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table India Key Players Ibandronate Market Share (2018-2019)
Table India Ibandronate Market Size by Type (2014-2019) (Million US$)
Table India Ibandronate Market Share by Type (2014-2019)
Table India Ibandronate Market Size by Application (2014-2019) (Million US$)
Table India Ibandronate Market Share by Application (2014-2019)
Figure Central & South America Ibandronate Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Ibandronate Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Ibandronate Market Share (2018-2019)
Table Central & South America Ibandronate Market Size by Type (2014-2019) (Million US$)
Table Central & South America Ibandronate Market Share by Type (2014-2019)
Table Central & South America Ibandronate Market Size by Application (2014-2019) (Million US$)
Table Central & South America Ibandronate Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Ibandronate Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Ibandronate Business (2014-2019)
Table Roche Recent Development
Table Apotex Company Details
Table Apotex Revenue in Ibandronate Business (2014-2019)(Million US$)
Figure Apotex Revenue Growth Rate in Ibandronate Business (2014-2019)
Table Apotex Recent Development
Table Mylan Company Details
Table Mylan Revenue in Ibandronate Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Ibandronate Business (2014-2019)
Table Mylan Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Ibandronate Business (2014-2019)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Ibandronate Business (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Dr Reddy's Laboratories Company Details
Table Dr Reddy's Laboratories Revenue in Ibandronate Business (2014-2019)(Million US$)
Figure Dr Reddy's Laboratories Revenue Growth Rate in Ibandronate Business (2014-2019)
Table Dr Reddy's Laboratories Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Revenue in Ibandronate Business (2014-2019)(Million US$)
Figure Aurobindo Pharma Revenue Growth Rate in Ibandronate Business (2014-2019)
Table Aurobindo Pharma Recent Development
Table MACLEODS Company Details
Table MACLEODS Revenue in Ibandronate Business (2014-2019)(Million US$)
Figure MACLEODS Revenue Growth Rate in Ibandronate Business (2014-2019)
Table MACLEODS Recent Development
Table Global Ibandronate Market Size by Regions (Million US$) 2019-2025
Figure Global Ibandronate Market Size Share by Regions (2019-2025)
Figure Global Ibandronate Market Size Share by Regions in 2025
Figure United States Ibandronate Market Size Forecast (2019-2025)(Million USD)
Figure Europe Ibandronate Market Size Forecast (2019-2025)(Million USD)
Figure China Ibandronate Market Size Forecast (2019-2025)(Million USD)
Figure Japan Ibandronate Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Ibandronate Market Size Forecast (2019-2025)(Million USD)
Figure India Ibandronate Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Ibandronate Market Size Forecast (2019-2025)(Million USD)
Table Global Ibandronate Market Size by Product (2019-2025) (Million US$)
Figure Global Ibandronate Market Size by Product (2019-2025)
Figure Global Ibandronate Market Size by Product in 2025
Table Global Ibandronate Market Size by Application (2019-2025) (Million US$)
Figure Global Ibandronate Market Size by Application (2019-2025)
Figure Global Ibandronate Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の注射用ドラッグデリバリー市場：市場規模・現状・予測 Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.North Ameri…- 世界のデシタビン薬市場：市場規模・現状・予測 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).In 2018, the global Decitabine…
- 世界の皮下注射市場：市場規模・現状・予測 A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …
- 世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
- 世界のシクロベンザプリン薬市場：市場規模・現状・予測 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…